COLCHICINE

COLCHICINE was reported 26564 times

COLCHICINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 X-LINKED LYMPHOPROLIFERATIVE SYNDROME 24 0.7273
1 RED BLOOD CELL SEDIMENTATION RATE 128 0.4588
2 FAMILIAL MEDITERRANEAN FEVER 65 0.3316
3 SERUM AMYLOID A PROTEIN INCREASED 47 0.3032
4 HEART FAILURE WITH PRESERVED EJECTION FRACTION 87 0.2959
5 CENTRAL NERVOUS SYSTEM LUPUS 47 0.2108
6 BODY MASS INDEX ABNORMAL 46 0.1885
7 GOUTY TOPHUS 39 0.1757
8 GRANULOMA SKIN 139 0.1693
9 BEHCET'S SYNDROME 23 0.1620
10 ENTHESOPATHY 245 0.1565
11 AUTOINFLAMMATORY DISEASE 25 0.1179
12 TYPE 2 LEPRA REACTION 22 0.1176
13 BLOOD PARATHYROID HORMONE DECREASED 157 0.1059
14 SEROSITIS 57 0.1031
15 TENOSYNOVITIS 254 0.0920
16 MYOPATHY TOXIC 53 0.0858
17 PANNICULITIS 188 0.0776
18 NEUROMYOPATHY 78 0.0732
19 GOUTY ARTHRITIS 55 0.0689
20 ALANINE AMINOTRANSFERASE ABNORMAL 140 0.0663
21 GOUT 1108 0.0617
22 RHEUMATOID NODULE 163 0.0591
23 PLEUROPERICARDITIS 23 0.0558
24 URTICARIAL VASCULITIS 28 0.0530
25 MYOPERICARDITIS 40 0.0513
26 EPISCLERITIS 35 0.0507
27 PERICARDITIS CONSTRICTIVE 21 0.0498
28 RHEUMATOID LUNG 46 0.0482
29 CHONDROCALCINOSIS 31 0.0475
30 MUSCLE ABSCESS 27 0.0433
31 C-REACTIVE PROTEIN ABNORMAL 262 0.0408
32 DEFAECATION DISORDER 27 0.0403
33 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 41 0.0386
34 HYPERPARATHYROIDISM SECONDARY 86 0.0343
35 LUPUS NEPHRITIS 63 0.0337
36 DRUG TOLERANCE DECREASED 94 0.0334
37 CHONDROCALCINOSIS PYROPHOSPHATE 25 0.0323
38 HYPERSENSITIVITY VASCULITIS 84 0.0320
39 TONGUE DISORDER 229 0.0316
40 SKIN NECROSIS 164 0.0316
41 NEPHROGENIC ANAEMIA 137 0.0295
42 ENTEROCOCCAL SEPSIS 23 0.0284
43 LOSS OF EMPLOYMENT 85 0.0281
44 PERICARDITIS 443 0.0263
45 MYOPATHY 222 0.0257
46 PNEUMONIA STREPTOCOCCAL 26 0.0237
47 ECHOCARDIOGRAM ABNORMAL 33 0.0236
48 PERICARDIAL HAEMORRHAGE 50 0.0228
49 VASCULAR PURPURA 27 0.0193
50 GRANULOMA 66 0.0190
51 CARDIAC TAMPONADE 86 0.0181
52 SECONDARY ADRENOCORTICAL INSUFFICIENCY 27 0.0179
53 MYOCARDIAL INJURY 20 0.0178
54 BLOOD URIC ACID INCREASED 100 0.0173
55 CUTANEOUS VASCULITIS 59 0.0161
56 WHITE BLOOD CELLS URINE POSITIVE 30 0.0159
57 ESSENTIAL HYPERTENSION 29 0.0158
58 TENDONITIS 245 0.0158
59 HYPERPHOSPHATAEMIA 34 0.0158
60 BLOOD PRESSURE DIASTOLIC ABNORMAL 40 0.0157
61 HYPERCALCAEMIA 194 0.0157
62 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 36 0.0155
63 RED BLOOD CELL SEDIMENTATION RATE INCREASED 167 0.0151
64 ULCER 237 0.0149
65 SYNOVITIS 268 0.0148
66 MULTIPLE ORGAN DYSFUNCTION SYNDROME 408 0.0144
67 PERICARDIAL EFFUSION 324 0.0140
68 LABELLED DRUG-DRUG INTERACTION ISSUE 20 0.0138
69 CARDIOGENIC SHOCK 198 0.0138
70 REBOUND ACID HYPERSECRETION 41 0.0135
71 BASAL CELL CARCINOMA 206 0.0132
72 ORTHOPNOEA 42 0.0132
73 END STAGE RENAL DISEASE 240 0.0131
74 RESPIRATORY ACIDOSIS 50 0.0127
75 MIXED LIVER INJURY 38 0.0126
76 TROPONIN I INCREASED 21 0.0126
77 RHABDOMYOLYSIS 520 0.0125
78 VASOPLEGIA SYNDROME 20 0.0122
79 FEAR OF INJECTION 86 0.0120
80 BICYTOPENIA 23 0.0117
81 LEUKOCYTOSIS 211 0.0116
82 GROWTH RETARDATION 34 0.0115
83 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 291 0.0113
84 DRUG TOLERANCE 57 0.0113
85 NEPHROGENIC SYSTEMIC FIBROSIS 34 0.0112
86 CONTRAINDICATED PRODUCT ADMINISTERED 339 0.0112
87 HEPATOSPLENOMEGALY 28 0.0109
88 MYOCARDITIS 123 0.0107
89 SKIN INDURATION 22 0.0106
90 DRUG ERUPTION 188 0.0106
91 ARTHRITIS INFECTIVE 49 0.0106
92 HYPERURICAEMIA 42 0.0102
93 JOINT NOISE 20 0.0102
94 BLOOD PRESSURE SYSTOLIC DECREASED 45 0.0099
95 HAEMORRHAGIC DIATHESIS 35 0.0098
96 THROMBOCYTOSIS 36 0.0098
97 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 26 0.0098
98 BLOOD PRESSURE SYSTOLIC ABNORMAL 24 0.0097
99 CYTOLYTIC HEPATITIS 32 0.0096
100 RENAL FAILURE CHRONIC 74 0.0096
101 METABOLIC ACIDOSIS 306 0.0096
102 PYODERMA GANGRENOSUM 34 0.0094
103 CORONARY ARTERY THROMBOSIS 19 0.0094
104 JAUNDICE CHOLESTATIC 33 0.0093
105 SKIN ULCER 239 0.0092
106 BLOOD PRESSURE SYSTOLIC INCREASED 180 0.0092
107 CARDIAC DYSFUNCTION 34 0.0091
108 C-REACTIVE PROTEIN INCREASED 328 0.0090
109 APPETITE DISORDER 59 0.0089
110 DISTRIBUTIVE SHOCK 20 0.0088
111 ISCHAEMIC CARDIOMYOPATHY 27 0.0088
112 MYOSITIS 78 0.0087
113 ACUTE KIDNEY INJURY 1318 0.0086
114 CHRONIC KIDNEY DISEASE 652 0.0086
115 TYPE IV HYPERSENSITIVITY REACTION 23 0.0084
116 ASPARTATE AMINOTRANSFERASE INCREASED 445 0.0084
117 HEPATIC CYTOLYSIS 104 0.0081
118 TROPONIN INCREASED 62 0.0081
119 BLOOD CHLORIDE DECREASED 21 0.0081
120 CUSHINGOID 26 0.0081
121 DISSEMINATED INTRAVASCULAR COAGULATION 113 0.0080
122 HEPATIC STEATOSIS 149 0.0080
123 ERYTHEMA NODOSUM 28 0.0080
124 RENAL FAILURE ACUTE 336 0.0079
125 BRAIN NATRIURETIC PEPTIDE INCREASED 24 0.0078
126 DERMATITIS EXFOLIATIVE GENERALISED 27 0.0078
127 ATELECTASIS 75 0.0078
128 BLOOD PRESSURE DIASTOLIC DECREASED 57 0.0077
129 HYPOVOLAEMIA 45 0.0077
130 HYPERVOLAEMIA 38 0.0077
131 PULSELESS ELECTRICAL ACTIVITY 32 0.0077
132 PLEURITIC PAIN 21 0.0076
133 JOINT EFFUSION 52 0.0075
134 HYPOVOLAEMIC SHOCK 36 0.0075
135 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 38 0.0075
136 COAGULOPATHY 125 0.0075
137 DRUG INTOLERANCE 721 0.0075
138 HYPERLACTACIDAEMIA 20 0.0075
139 PLEURISY 44 0.0074
140 PANCYTOPENIA 412 0.0074
141 SHOCK 169 0.0073
142 CONJUNCTIVAL HAEMORRHAGE 28 0.0073
143 TOXICITY TO VARIOUS AGENTS 1230 0.0073
144 ABDOMINAL TENDERNESS 36 0.0072
145 RENAL TUBULAR NECROSIS 71 0.0072
146 MULTI-ORGAN FAILURE 125 0.0072
147 LUNG OPACITY 19 0.0072
148 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 63 0.0071
149 APHTHOUS ULCER 55 0.0071
150 OLIGURIA 44 0.0071
151 DRUG INTERACTION 1119 0.0070
152 ALANINE AMINOTRANSFERASE INCREASED 432 0.0070
153 INFUSION SITE HAEMORRHAGE 23 0.0070
154 RED CELL DISTRIBUTION WIDTH INCREASED 29 0.0070
155 INFUSION SITE PRURITUS 22 0.0070
156 BLOOD PHOSPHORUS INCREASED 19 0.0070
157 CHOLESTASIS 132 0.0069
158 GENERALISED ERYTHEMA 39 0.0069
159 NEUTROPHILIA 39 0.0068
160 POTENTIATING DRUG INTERACTION 23 0.0068
161 POLYARTHRITIS 36 0.0068
162 TENDERNESS 71 0.0068
163 INTERNATIONAL NORMALISED RATIO INCREASED 194 0.0068
164 PSORIATIC ARTHROPATHY 276 0.0068
165 ANTINUCLEAR ANTIBODY POSITIVE 22 0.0068
166 SKIN HYPERTROPHY 19 0.0068
167 DYSPHORIA 34 0.0067
168 BODY TEMPERATURE DECREASED 66 0.0067
169 HYPERKALAEMIA 235 0.0067
170 HYPERLIPIDAEMIA 80 0.0067
171 TRICUSPID VALVE INCOMPETENCE 53 0.0067
172 CONCOMITANT DISEASE AGGRAVATED 41 0.0066
173 URINE OUTPUT DECREASED 58 0.0066
174 RENAL FAILURE 877 0.0066
175 THERAPY NON-RESPONDER 296 0.0066
176 RIGHT VENTRICULAR FAILURE 46 0.0066
177 VASCULITIS 76 0.0065
178 ATRIAL FLUTTER 52 0.0065
179 DYSLIPIDAEMIA 33 0.0065
180 CARDIOMYOPATHY 96 0.0065
181 JOINT INJURY 138 0.0065
182 SERUM FERRITIN INCREASED 34 0.0064
183 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 50 0.0064
184 GLUCOSE TOLERANCE IMPAIRED 38 0.0064
185 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 348 0.0063
186 DIVERTICULUM 45 0.0063
187 BLOOD UREA INCREASED 106 0.0063
188 FAECES SOFT 46 0.0063
189 BLOOD CREATINE PHOSPHOKINASE INCREASED 182 0.0063
190 BUNDLE BRANCH BLOCK RIGHT 29 0.0063
191 HEPATITIS ACUTE 41 0.0063
192 BONE MARROW FAILURE 128 0.0063
193 ACUTE RESPIRATORY FAILURE 121 0.0063
194 CARDIOMEGALY 77 0.0063
195 HYPOMAGNESAEMIA 86 0.0062
196 INFUSION SITE ERYTHEMA 52 0.0062
197 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 293 0.0061
198 ARTHRITIS BACTERIAL 25 0.0061
199 DIABETIC NEUROPATHY 30 0.0061
200 HAEMODYNAMIC INSTABILITY 46 0.0060
201 REBOUND EFFECT 68 0.0060
202 BENIGN PROSTATIC HYPERPLASIA 31 0.0060
203 DRUG RESISTANCE 154 0.0060
204 PURPURA 53 0.0060
205 INFLAMMATION 309 0.0060
206 INTERNATIONAL NORMALISED RATIO DECREASED 24 0.0059
207 TOXIC EPIDERMAL NECROLYSIS 90 0.0059
208 ACIDOSIS 45 0.0059
209 FOOD ALLERGY 45 0.0058
210 AORTIC STENOSIS 20 0.0057
211 HAEMORRHAGIC ANAEMIA 25 0.0057
212 TUBULOINTERSTITIAL NEPHRITIS 106 0.0057
213 BLOOD CREATININE INCREASED 366 0.0056
214 MOUTH ULCERATION 118 0.0056
215 MATERNAL EXPOSURE TIMING UNSPECIFIED 21 0.0056
216 ABNORMAL LOSS OF WEIGHT 38 0.0056
217 ACUTE HEPATIC FAILURE 76 0.0056
218 HEART RATE ABNORMAL 31 0.0056
219 RALES 32 0.0055
220 MONOCYTE COUNT INCREASED 20 0.0055
221 HAEMOGLOBIN INCREASED 25 0.0055
222 BREATH SOUNDS ABNORMAL 27 0.0055
223 BUNDLE BRANCH BLOCK LEFT 23 0.0054
224 RASH MACULO-PAPULAR 120 0.0054
225 PROTHROMBIN TIME PROLONGED 32 0.0053
226 HYDRONEPHROSIS 40 0.0053
227 SKIN PLAQUE 45 0.0053
228 SKIN WARM 31 0.0053
229 BLOOD LACTIC ACID INCREASED 28 0.0053
230 UPPER GASTROINTESTINAL HAEMORRHAGE 89 0.0053
231 VITAMIN D DECREASED 45 0.0053
232 TONGUE OEDEMA 20 0.0052
233 HYPOCALCAEMIA 99 0.0052
234 TREATMENT FAILURE 433 0.0052
235 EOSINOPHILIA 91 0.0052
236 THERAPEUTIC PRODUCT EFFECT DECREASED 232 0.0052
237 RENAL INJURY 153 0.0051
238 SUSPECTED SUICIDE 24 0.0051
239 ASPIRATION 56 0.0051
240 CARDIAC FAILURE ACUTE 34 0.0051
241 CLOSTRIDIUM DIFFICILE COLITIS 54 0.0051
242 CARDIAC FAILURE CONGESTIVE 408 0.0051
243 HEPATOCELLULAR INJURY 72 0.0051
244 ACCIDENTAL EXPOSURE 21 0.0050
245 ENTEROCOLITIS 29 0.0050
246 RENAL IMPAIRMENT 418 0.0050
247 MATERNAL EXPOSURE DURING BREAST FEEDING 20 0.0049
248 LEUKOPENIA 246 0.0049
249 LEFT VENTRICULAR HYPERTROPHY 21 0.0049
250 INFUSION SITE PAIN 63 0.0049
251 HYPERTRANSAMINASAEMIA 34 0.0049
252 THERAPY PARTIAL RESPONDER 76 0.0049
253 OSTEOMYELITIS 88 0.0049
254 MITRAL VALVE INCOMPETENCE 55 0.0049
255 ARTHRITIS 380 0.0048
256 ANGIOPATHY 27 0.0048
257 VENTRICULAR TACHYCARDIA 79 0.0048
258 RASH PRURITIC 259 0.0048
259 INFUSION SITE SWELLING 30 0.0048
260 TOXIC SKIN ERUPTION 48 0.0048
261 ANURIA 41 0.0048
262 UVEITIS 64 0.0047
263 HEPATIC FAILURE 142 0.0047
264 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 32 0.0047
265 HEPATOTOXICITY 104 0.0047
266 SHOCK HAEMORRHAGIC 38 0.0047
267 MUSCLE ATROPHY 59 0.0047
268 INTENTIONAL OVERDOSE 298 0.0046
269 HAEMATURIA 159 0.0046
270 ECONOMIC PROBLEM 70 0.0046
271 ANAPHYLACTOID REACTION 19 0.0046
272 SPLENOMEGALY 54 0.0046
273 CELLULITIS 230 0.0046
274 GLOMERULAR FILTRATION RATE DECREASED 56 0.0046
275 CARDIAC VALVE DISEASE 26 0.0045
276 THROMBOCYTOPENIA 507 0.0045
277 RENAL CYST 36 0.0045
278 GENERALISED OEDEMA 56 0.0045
279 ACUTE RESPIRATORY DISTRESS SYNDROME 80 0.0045
280 PANCREATITIS ACUTE 101 0.0045
281 CORONARY ARTERY DISEASE 136 0.0045
282 IRON DEFICIENCY 20 0.0044
283 SINUS CONGESTION 60 0.0044
284 INFLAMMATORY MARKER INCREASED 22 0.0044
285 PULMONARY HYPERTENSION 92 0.0044
286 AGRANULOCYTOSIS 82 0.0044
287 VASCULAR DEVICE INFECTION 20 0.0044
288 NEPHROPATHY 41 0.0044
289 ARTERIOSCLEROSIS CORONARY ARTERY 29 0.0044
290 DRUG LEVEL ABOVE THERAPEUTIC 20 0.0044
291 LACTIC ACIDOSIS 141 0.0043
292 INFUSION RELATED REACTION 288 0.0043
293 GUILLAIN-BARRE SYNDROME 21 0.0043
294 CARDIAC FAILURE 348 0.0043
295 BLOOD PRESSURE FLUCTUATION 104 0.0043
296 LIVER FUNCTION TEST INCREASED 93 0.0043
297 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
298 VENTRICULAR FIBRILLATION 48 0.0043
299 GASTROINTESTINAL MOTILITY DISORDER 23 0.0043
300 PULMONARY MASS 64 0.0043
301 WRONG PRODUCT ADMINISTERED 29 0.0043
302 MULTIPLE INJURIES 27 0.0043
303 PERIPHERAL VASCULAR DISORDER 22 0.0043
304 HYPERAESTHESIA 35 0.0043
305 JOINT RANGE OF MOTION DECREASED 57 0.0042
306 COLITIS MICROSCOPIC 20 0.0042
307 PETECHIAE 44 0.0042
308 MUSCULOSKELETAL DISORDER 80 0.0042
309 COMPLETED SUICIDE 350 0.0042
310 ATRIAL FIBRILLATION 409 0.0042
311 SKIN HYPERPIGMENTATION 36 0.0042
312 LIVER INJURY 102 0.0042
313 KLEBSIELLA INFECTION 21 0.0041
314 PULMONARY FIBROSIS 79 0.0041
315 BLOOD PRESSURE DIASTOLIC INCREASED 19 0.0041
316 PLEURAL EFFUSION 250 0.0041
317 HYPERTRIGLYCERIDAEMIA 24 0.0041
318 HEART RATE IRREGULAR 92 0.0041
319 LYMPHADENOPATHY 144 0.0041
320 FLANK PAIN 38 0.0040
321 STAPHYLOCOCCAL SEPSIS 20 0.0040
322 STEVENS-JOHNSON SYNDROME 90 0.0040
323 FAILURE TO THRIVE 21 0.0040
324 SKIN TIGHTNESS 19 0.0040
325 OSTEOARTHRITIS 171 0.0040
326 IRON DEFICIENCY ANAEMIA 37 0.0040
327 MELAENA 88 0.0040
328 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 30 0.0040
329 HAEMATOCRIT DECREASED 79 0.0040
330 TENDON RUPTURE 49 0.0040
331 MUSCULOSKELETAL STIFFNESS 346 0.0039
332 ACUTE MYOCARDIAL INFARCTION 116 0.0039
333 RHEUMATOID ARTHRITIS 446 0.0039
334 BLOOD LACTATE DEHYDROGENASE INCREASED 62 0.0039
335 HYPOXIA 137 0.0039
336 ANGIOEDEMA 172 0.0039
337 SEASONAL ALLERGY 55 0.0039
338 GRIP STRENGTH DECREASED 34 0.0039
339 TRANSAMINASES INCREASED 85 0.0038
340 PULMONARY ARTERIAL HYPERTENSION 55 0.0038
341 SEPTIC SHOCK 165 0.0038
342 ILEUS 47 0.0038
343 DIARRHOEA 2429 0.0038
344 SINUS TACHYCARDIA 53 0.0037
345 HYPOTENSION 746 0.0037
346 RESPIRATORY RATE INCREASED 33 0.0037
347 OEDEMA PERIPHERAL 453 0.0037
348 GASTROINTESTINAL DISORDER 332 0.0037
349 OBESITY 59 0.0037
350 PHARYNGITIS STREPTOCOCCAL 40 0.0037
351 RESPIRATORY TRACT INFECTION 96 0.0037
352 OEDEMA 199 0.0037
353 RESPIRATORY DISTRESS 101 0.0037
354 BLOOD ALBUMIN DECREASED 29 0.0037
355 HEPATITIS CHOLESTATIC 22 0.0036
356 ECCHYMOSIS 25 0.0036
357 SQUAMOUS CELL CARCINOMA OF SKIN 22 0.0036
358 NEUTROPENIC SEPSIS 26 0.0036
359 PULMONARY OEDEMA 163 0.0036
360 WEIGHT FLUCTUATION 38 0.0036
361 ATRIOVENTRICULAR BLOCK 28 0.0036
362 DISEASE RECURRENCE 172 0.0036
363 TACHYPNOEA 49 0.0036
364 ENTERITIS 23 0.0036
365 CARDIAC MURMUR 31 0.0036
366 PERIPHERAL SWELLING 550 0.0036
367 GASTROINTESTINAL HAEMORRHAGE 298 0.0036
368 ACUTE PULMONARY OEDEMA 20 0.0036
369 SLEEP APNOEA SYNDROME 68 0.0036
370 BLOOD CALCIUM DECREASED 40 0.0036
371 HEPATITIS 91 0.0036
372 ADRENAL INSUFFICIENCY 43 0.0035
373 EJECTION FRACTION DECREASED 55 0.0035
374 HERPES SIMPLEX 23 0.0035
375 THERAPEUTIC RESPONSE DECREASED 214 0.0035
376 JOINT SWELLING 426 0.0035
377 ELECTROLYTE IMBALANCE 41 0.0035
378 SPINAL OSTEOARTHRITIS 31 0.0035
379 HEPATIC ENZYME INCREASED 240 0.0035
380 SQUAMOUS CELL CARCINOMA 33 0.0035
381 SKIN DISORDER 115 0.0034
382 ABDOMINAL PAIN 802 0.0034
383 POST PROCEDURAL INFECTION 28 0.0034
384 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
385 ATRIOVENTRICULAR BLOCK COMPLETE 23 0.0034
386 WOUND 96 0.0034
387 DYSPNOEA EXERTIONAL 129 0.0034
388 NEUTROPHIL COUNT INCREASED 35 0.0034
389 CHEST PAIN 633 0.0034
390 BRONCHIECTASIS 23 0.0034
391 MOUTH HAEMORRHAGE 25 0.0034
392 LIVER FUNCTION TEST ABNORMAL 99 0.0034
393 MALNUTRITION 38 0.0034
394 CLOSTRIDIUM DIFFICILE INFECTION 74 0.0034
395 HYPOPHOSPHATAEMIA 25 0.0034
396 LIVER DISORDER 150 0.0034
397 CARDIAC ARREST 279 0.0034
398 VENTRICULAR EXTRASYSTOLES 35 0.0034
399 FLUID OVERLOAD 49 0.0034
400 HAEMOLYSIS 26 0.0034
401 GASTRIC DISORDER 115 0.0033
402 SYMPTOM RECURRENCE 20 0.0033
403 OSTEOPOROSIS 136 0.0033
404 PHARYNGITIS 41 0.0033
405 DIZZINESS POSTURAL 32 0.0033
406 HAEMOPTYSIS 92 0.0033
407 RESPIRATORY FAILURE 239 0.0033
408 HYPOKALAEMIA 151 0.0033
409 ARTHRALGIA 1356 0.0033
410 GENERAL PHYSICAL HEALTH DETERIORATION 376 0.0032
411 JOINT STIFFNESS 85 0.0032
412 ARTHROPATHY 180 0.0032
413 PLATELET COUNT INCREASED 42 0.0032
414 SEPSIS 359 0.0032
415 HEPATIC FUNCTION ABNORMAL 120 0.0032
416 BURSITIS 39 0.0032
417 PREMATURE DELIVERY 51 0.0032
418 BLOOD POTASSIUM INCREASED 52 0.0032
419 ARTERIOSCLEROSIS 30 0.0032
420 CARDIAC PACEMAKER INSERTION 19 0.0032
421 DRUG-INDUCED LIVER INJURY 100 0.0032
422 HAEMATEMESIS 80 0.0032
423 SYSTEMIC LUPUS ERYTHEMATOSUS 112 0.0032
424 CARPAL TUNNEL SYNDROME 44 0.0031
425 DEFAECATION URGENCY 22 0.0031
426 ASCITES 92 0.0031
427 PRODUCTIVE COUGH 149 0.0031
428 HYPERCHOLESTEROLAEMIA 30 0.0031
429 BLOOD ALKALINE PHOSPHATASE INCREASED 77 0.0031
430 HAEMODIALYSIS 26 0.0031
431 ABDOMINAL DISCOMFORT 519 0.0031
432 MYOCARDIAL ISCHAEMIA 35 0.0031
433 DEHYDRATION 410 0.0031
434 GLAUCOMA 59 0.0031
435 ANHEDONIA 80 0.0030
436 LYMPHOPENIA 43 0.0030
437 HAEMOGLOBIN DECREASED 312 0.0030
438 MYALGIA 515 0.0030
439 LIMB INJURY 82 0.0030
440 DRUG TOXICITY 41 0.0030
441 IMPAIRED GASTRIC EMPTYING 41 0.0030
442 LIPASE INCREASED 23 0.0030
443 SUICIDE ATTEMPT 180 0.0030
444 RENAL DISORDER 138 0.0030
445 DRUG LEVEL INCREASED 49 0.0030
446 ORAL PAIN 66 0.0029
447 GASTRIC ULCER 56 0.0029
448 LUNG INFILTRATION 26 0.0029
449 ANAEMIA 561 0.0029
450 EAR PAIN 57 0.0029
451 CONDITION AGGRAVATED 890 0.0029
452 HAEMORRHOIDS 57 0.0029
453 MENTAL STATUS CHANGES 81 0.0029
454 MUSCULOSKELETAL CHEST PAIN 45 0.0029
455 ACUTE CORONARY SYNDROME 24 0.0029
456 BLOOD MAGNESIUM DECREASED 25 0.0029
457 HYPERTENSION 611 0.0029
458 STAPHYLOCOCCAL INFECTION 95 0.0029
459 GASTROENTERITIS 42 0.0029
460 VITAMIN D DEFICIENCY 28 0.0029
461 FLUID RETENTION 146 0.0029
462 LUPUS-LIKE SYNDROME 26 0.0029
463 ORAL DISORDER 21 0.0029
464 CHOLECYSTITIS 34 0.0029
465 GAMMA-GLUTAMYLTRANSFERASE INCREASED 63 0.0028
466 QUALITY OF LIFE DECREASED 38 0.0028
467 HYPOKINESIA 41 0.0028
468 HYPONATRAEMIA 159 0.0028
469 INTERVERTEBRAL DISC DEGENERATION 26 0.0028
470 DYSSTASIA 82 0.0028
471 MUSCLE STRAIN 24 0.0028
472 NECK PAIN 155 0.0028
473 MYOCLONUS 33 0.0028
474 EPISTAXIS 206 0.0028
475 PAIN IN JAW 78 0.0028
476 HEPATOMEGALY 27 0.0027
477 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 195 0.0027
478 MIOSIS 22 0.0027
479 WHITE BLOOD CELL COUNT INCREASED 105 0.0027
480 SKIN LESION 75 0.0027
481 PNEUMONIA BACTERIAL 25 0.0027
482 MOBILITY DECREASED 195 0.0027
483 PHOTOPHOBIA 51 0.0027
484 LETHARGY 156 0.0027
485 HIATUS HERNIA 35 0.0027
486 CORONARY ARTERY OCCLUSION 37 0.0027
487 POLYURIA 22 0.0027
488 MULTIPLE ALLERGIES 21 0.0027
489 HEART RATE DECREASED 94 0.0027
490 APPENDICITIS 25 0.0027
491 MUSCULOSKELETAL DISCOMFORT 46 0.0027
492 CANDIDA INFECTION 45 0.0027
493 BLOOD POTASSIUM DECREASED 80 0.0027
494 RECTAL HAEMORRHAGE 114 0.0027
495 LOCALISED INFECTION 64 0.0026
496 MUSCULAR WEAKNESS 300 0.0026
497 VOMITING 1240 0.0026
498 FOOT FRACTURE 50 0.0026
499 OSTEOPENIA 40 0.0026
500 ERYTHEMA 540 0.0026
501 PRODUCT ADMINISTRATION ERROR 53 0.0026
502 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
503 NEPHROLITHIASIS 120 0.0026
504 TUMOUR LYSIS SYNDROME 23 0.0026
505 PYREXIA 903 0.0026
506 PALLOR 71 0.0026
507 RHINITIS 21 0.0026
508 PNEUMONIA ASPIRATION 65 0.0026
509 SINUS BRADYCARDIA 25 0.0026
510 BLISTER 145 0.0026
511 OFF LABEL USE 2256 0.0026
512 HAEMOLYTIC ANAEMIA 23 0.0026
513 MYELODYSPLASTIC SYNDROME 37 0.0026
514 IMMUNODEFICIENCY 38 0.0025
515 RENAL PAIN 27 0.0025
516 LYMPHOCYTE COUNT DECREASED 45 0.0025
517 ACCIDENTAL OVERDOSE 93 0.0025
518 INTERSTITIAL LUNG DISEASE 123 0.0025
519 CATARACT 151 0.0025
520 ORTHOSTATIC HYPOTENSION 44 0.0025
521 COUGH 707 0.0025
522 HYPOPHAGIA 64 0.0025
523 PULMONARY CONGESTION 33 0.0025
524 INCREASED TENDENCY TO BRUISE 23 0.0025
525 NEUTROPENIA 339 0.0025
526 FAECES DISCOLOURED 54 0.0025
527 RED BLOOD CELL COUNT DECREASED 71 0.0025
528 EMPHYSEMA 25 0.0025
529 PROTEINURIA 47 0.0025
530 BLOOD PRESSURE DECREASED 164 0.0025
531 CYTOPENIA 30 0.0024
532 HYPOALBUMINAEMIA 19 0.0024
533 MYELOSUPPRESSION 88 0.0024
534 CONTUSION 235 0.0024
535 OROPHARYNGEAL DISCOMFORT 22 0.0024
536 HAEMATOMA 63 0.0024
537 RIB FRACTURE 50 0.0024
538 OVERDOSE 524 0.0024
539 TOOTH DISORDER 54 0.0024
540 ANKYLOSING SPONDYLITIS 32 0.0024
541 ANAPHYLACTIC REACTION 134 0.0024
542 DYSPNOEA 1372 0.0024
543 METASTASES TO LUNG 28 0.0024
544 HEREDITARY ANGIOEDEMA 26 0.0024
545 ARTERIAL OCCLUSIVE DISEASE 19 0.0024
546 SNEEZING 54 0.0024
547 NEPHROPATHY TOXIC 27 0.0024
548 EYE HAEMORRHAGE 32 0.0024
549 DIALYSIS 34 0.0024
550 GAIT INABILITY 80 0.0024
551 GROIN PAIN 21 0.0024
552 UROSEPSIS 22 0.0024
553 ABSCESS 38 0.0024
554 DRUG LEVEL DECREASED 24 0.0024
555 DIARRHOEA HAEMORRHAGIC 22 0.0024
556 BACK PAIN 545 0.0023
557 DYSPHONIA 137 0.0023
558 ANGINA PECTORIS 67 0.0023
559 BRADYCARDIA 124 0.0023
560 UPPER RESPIRATORY TRACT INFECTION 108 0.0023
561 BLOOD PRESSURE INCREASED 357 0.0023
562 PSEUDOMONAS INFECTION 20 0.0023
563 PNEUMONIA 755 0.0023
564 OXYGEN SATURATION DECREASED 131 0.0023
565 INFECTION 336 0.0023
566 POOR VENOUS ACCESS 24 0.0023
567 BLOOD URINE PRESENT 44 0.0023
568 TASTE DISORDER 47 0.0023
569 DECREASED APPETITE 538 0.0023
570 OCULAR DISCOMFORT 26 0.0023
571 RESTLESS LEGS SYNDROME 42 0.0023
572 PYELONEPHRITIS 20 0.0023
573 ORAL HERPES 45 0.0023
574 ASTHENIA 866 0.0023
575 HIDRADENITIS 21 0.0023
576 SKIN LACERATION 25 0.0023
577 GASTROOESOPHAGEAL REFLUX DISEASE 185 0.0023
578 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
579 WEIGHT DECREASED 640 0.0023
580 TRANSFUSION 24 0.0023
581 HYPOGLYCAEMIA 111 0.0023
582 OESOPHAGITIS 25 0.0023
583 NAUSEA 1810 0.0023
584 BLOOD SODIUM DECREASED 43 0.0023
585 EOSINOPHIL COUNT INCREASED 19 0.0023
586 RASH 993 0.0023
587 INTERNAL HAEMORRHAGE 26 0.0023
588 PAIN IN EXTREMITY 670 0.0023
589 INTENTIONAL PRODUCT USE ISSUE 199 0.0023
590 SWELLING 212 0.0023
591 CONJUNCTIVITIS 42 0.0023
592 TOOTH ABSCESS 23 0.0023
593 SCIATICA 36 0.0023
594 GASTRITIS 59 0.0022
595 PARALYSIS 32 0.0022
596 TEMPERATURE INTOLERANCE 23 0.0022
597 HAEMATOCHEZIA 123 0.0022
598 INTESTINAL OBSTRUCTION 84 0.0022
599 HOSPICE CARE 22 0.0022
600 INTESTINAL PERFORATION 25 0.0022
601 PREMATURE BABY 67 0.0022
602 LIP SWELLING 74 0.0022
603 DELIRIUM 77 0.0022
604 MASS 31 0.0022
605 CHILLS 260 0.0022
606 ARRHYTHMIA 105 0.0022
607 BLOOD TRIGLYCERIDES INCREASED 39 0.0022
608 BODY TEMPERATURE INCREASED 45 0.0022
609 HYPERSENSITIVITY 409 0.0022
610 HYPERGLYCAEMIA 80 0.0022
611 NASAL CONGESTION 129 0.0022
612 DERMATITIS CONTACT 25 0.0022
613 HEPATIC CIRRHOSIS 41 0.0022
614 ROTATOR CUFF SYNDROME 28 0.0022
615 MUCOSAL INFLAMMATION 57 0.0022
616 CYST 27 0.0022
617 PNEUMONITIS 59 0.0022
618 BLOOD CALCIUM INCREASED 19 0.0022
619 CYTOMEGALOVIRUS INFECTION 36 0.0022
620 FOOT DEFORMITY 24 0.0022
621 LIMB DISCOMFORT 67 0.0022
622 PRODUCT PRESCRIBING ISSUE 47 0.0022
623 DRY MOUTH 175 0.0022
624 PRODUCT USE ISSUE 405 0.0022
625 TOOTHACHE 39 0.0022
626 ABDOMINAL PAIN UPPER 442 0.0021
627 PHARYNGEAL SWELLING 21 0.0021
628 BACTERIAL INFECTION 40 0.0021
629 NOCTURIA 26 0.0021
630 HYPERTHYROIDISM 31 0.0021
631 URTICARIA 354 0.0021
632 BLOOD PRESSURE ABNORMAL 42 0.0021
633 FATIGUE 1644 0.0021
634 URINARY TRACT INFECTION 360 0.0021
635 ABDOMINAL DISTENSION 220 0.0021
636 BRAIN FOG 33 0.0021
637 CARDIO-RESPIRATORY ARREST 88 0.0021
638 SCAB 24 0.0021
639 RHINORRHOEA 136 0.0021
640 SCAR 36 0.0021
641 WOUND INFECTION 23 0.0021
642 OROPHARYNGEAL PAIN 194 0.0021
643 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
644 HEART RATE INCREASED 207 0.0021
645 NIGHT SWEATS 67 0.0021
646 FACE OEDEMA 35 0.0021
647 TACHYCARDIA 184 0.0021
648 POISONING 26 0.0021
649 PHOTOSENSITIVITY REACTION 34 0.0021
650 DIVERTICULITIS 57 0.0021
651 CIRCULATORY COLLAPSE 35 0.0021
652 AUTOIMMUNE DISORDER 20 0.0020
653 GINGIVAL BLEEDING 28 0.0020
654 SPINAL PAIN 24 0.0020
655 CHOLELITHIASIS 67 0.0020
656 HEADACHE 1279 0.0020
657 NEUROPATHY PERIPHERAL 193 0.0020
658 BACTERAEMIA 24 0.0020
659 SINUS DISORDER 40 0.0020
660 PRESYNCOPE 49 0.0020
661 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 105 0.0020
662 COVID-19 353 0.0020
663 NODULE 26 0.0020
664 KIDNEY INFECTION 39 0.0020
665 TRANSIENT ISCHAEMIC ATTACK 67 0.0020
666 MUSCULOSKELETAL PAIN 104 0.0020
667 LOSS OF CONSCIOUSNESS 254 0.0020
668 TREATMENT NONCOMPLIANCE 108 0.0020
669 WHEEZING 117 0.0020
670 CYANOSIS 31 0.0020
671 PERIPHERAL COLDNESS 27 0.0020
672 EXPOSURE DURING PREGNANCY 122 0.0020
673 ISCHAEMIC STROKE 35 0.0020
674 BRONCHITIS 145 0.0020
675 DIABETES MELLITUS 149 0.0020
676 HALLUCINATION 147 0.0019
677 LYMPHOMA 30 0.0019
678 DYSPHAGIA 184 0.0019
679 THERAPY CHANGE 19 0.0019
680 THINKING ABNORMAL 36 0.0019
681 HYPERBILIRUBINAEMIA 20 0.0019
682 HEAD INJURY 61 0.0019
683 MEDICATION ERROR 107 0.0019
684 POLYNEUROPATHY 23 0.0019
685 HYPOTHYROIDISM 61 0.0019
686 GASTROINTESTINAL PAIN 21 0.0019
687 DERMATITIS ALLERGIC 24 0.0019
688 COLITIS 72 0.0019
689 SYNCOPE 190 0.0019
690 MALAISE 832 0.0019
691 TOOTH INFECTION 25 0.0019
692 NEURALGIA 46 0.0019
693 CARDIOVASCULAR DISORDER 48 0.0019
694 FLATULENCE 107 0.0019
695 PRODUCT USE IN UNAPPROVED INDICATION 467 0.0019
696 INTERVERTEBRAL DISC PROTRUSION 41 0.0019
697 WEIGHT INCREASED 420 0.0019
698 DERMATITIS 39 0.0019
699 PANCREATITIS 98 0.0019
700 BLOOD IRON DECREASED 22 0.0019
701 FIBROMYALGIA 45 0.0018
702 PAIN 1135 0.0018
703 MACULAR DEGENERATION 22 0.0018
704 EAR INFECTION 49 0.0018
705 FULL BLOOD COUNT DECREASED 37 0.0018
706 SINUSITIS 188 0.0018
707 VIRAL INFECTION 61 0.0018
708 GASTROENTERITIS VIRAL 33 0.0018
709 FALL 608 0.0018
710 CONSTIPATION 398 0.0018
711 FEBRILE NEUTROPENIA 121 0.0018
712 ORAL CANDIDIASIS 24 0.0018
713 PALPITATIONS 212 0.0018
714 DISCOMFORT 110 0.0018
715 NERVE INJURY 20 0.0018
716 CHEST DISCOMFORT 183 0.0018
717 SKIN INFECTION 20 0.0018
718 BLOOD COUNT ABNORMAL 27 0.0018
719 BLOOD TEST ABNORMAL 25 0.0018
720 HYPOAESTHESIA 266 0.0018
721 BLOOD BILIRUBIN INCREASED 48 0.0018
722 SKIN DISCOLOURATION 81 0.0018
723 GAIT DISTURBANCE 337 0.0018
724 COLD SWEAT 31 0.0018
725 DEVICE RELATED INFECTION 27 0.0018
726 DYSPEPSIA 172 0.0017
727 JAUNDICE 47 0.0017
728 SUBDURAL HAEMATOMA 25 0.0017
729 PULMONARY THROMBOSIS 19 0.0017
730 LUNG DISORDER 85 0.0017
731 SWOLLEN TONGUE 54 0.0017
732 BONE PAIN 101 0.0017
733 IMPAIRED HEALING 56 0.0017
734 UNRESPONSIVE TO STIMULI 44 0.0017
735 ABASIA 42 0.0017
736 RASH GENERALISED 44 0.0017
737 TYPE 2 DIABETES MELLITUS 57 0.0017
738 FISTULA 19 0.0017
739 RETCHING 36 0.0017
740 HYPERHIDROSIS 217 0.0017
741 GALLBLADDER DISORDER 30 0.0017
742 PLATELET COUNT DECREASED 179 0.0017
743 CARDIAC DISORDER 157 0.0017
744 HYPERSOMNIA 48 0.0017
745 BLOOD CHOLESTEROL INCREASED 78 0.0017
746 POOR QUALITY SLEEP 36 0.0017
747 ACTIVITIES OF DAILY LIVING IMPAIRED 33 0.0017
748 EYE PAIN 94 0.0017
749 INJURY 117 0.0017
750 HALLUCINATION, VISUAL 35 0.0017
751 GASTRIC HAEMORRHAGE 19 0.0016
752 ELECTROCARDIOGRAM QT PROLONGED 59 0.0016
753 BURNING SENSATION 115 0.0016
754 CONFUSIONAL STATE 265 0.0016
755 PNEUMOTHORAX 26 0.0016
756 RESPIRATORY DISORDER 49 0.0016
757 NASOPHARYNGITIS 299 0.0016
758 ABDOMINAL PAIN LOWER 41 0.0016
759 INJECTION SITE EXTRAVASATION 20 0.0016
760 PARAESTHESIA 255 0.0016
761 DRUG EFFECT LESS THAN EXPECTED 24 0.0016
762 URINARY RETENTION 54 0.0016
763 HIP FRACTURE 52 0.0016
764 MYOCARDIAL INFARCTION 282 0.0016
765 COVID-19 PNEUMONIA 19 0.0016
766 LUNG INFECTION 25 0.0016
767 DEAFNESS 42 0.0016
768 RASH PAPULAR 36 0.0016
769 RASH MACULAR 56 0.0016
770 IMPAIRED QUALITY OF LIFE 23 0.0016
771 SWELLING FACE 104 0.0016
772 HOT FLUSH 120 0.0016
773 DIZZINESS 794 0.0016
774 FRACTURE 30 0.0016
775 ALOPECIA 311 0.0016
776 BLOOD GLUCOSE ABNORMAL 29 0.0016
777 RASH ERYTHEMATOUS 75 0.0016
778 THROAT IRRITATION 70 0.0016
779 DRUG INEFFECTIVE 2052 0.0016
780 DEEP VEIN THROMBOSIS 101 0.0016
781 PRODUCT PRESCRIBING ERROR 37 0.0016
782 INSOMNIA 413 0.0015
783 STOMATITIS 94 0.0015
784 DYSURIA 57 0.0015
785 CEREBRAL HAEMORRHAGE 55 0.0015
786 MUSCLE SPASMS 281 0.0015
787 SLEEP DISORDER 108 0.0015
788 WHITE BLOOD CELL COUNT DECREASED 165 0.0015
789 PRURITUS 583 0.0015
790 THROAT TIGHTNESS 41 0.0015
791 INFLUENZA 169 0.0015
792 HERPES ZOSTER 87 0.0015
793 ANAPHYLACTIC SHOCK 39 0.0015
794 INJECTION SITE WARMTH 31 0.0015
795 APHONIA 21 0.0015
796 HERNIA 29 0.0015
797 PRESCRIBED OVERDOSE 29 0.0015
798 SPINAL FRACTURE 30 0.0015
799 PERITONITIS 31 0.0015
800 LOWER RESPIRATORY TRACT INFECTION 68 0.0015
801 INTENTIONAL DOSE OMISSION 42 0.0015
802 DIABETIC KETOACIDOSIS 35 0.0015
803 UPPER LIMB FRACTURE 29 0.0015
804 FEELING HOT 89 0.0015
805 CYSTITIS 46 0.0014
806 AGEUSIA 36 0.0014
807 SKIN CANCER 31 0.0014
808 DISORIENTATION 57 0.0014
809 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 42 0.0014
810 MOVEMENT DISORDER 46 0.0014
811 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
812 THYROID DISORDER 22 0.0014
813 ILLNESS 147 0.0014
814 HAEMORRHAGE 149 0.0014
815 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 256 0.0014
816 DYSARTHRIA 53 0.0014
817 POLLAKIURIA 58 0.0014
818 INJECTION SITE URTICARIA 34 0.0014
819 ENCEPHALOPATHY 34 0.0014
820 PULMONARY EMBOLISM 131 0.0014
821 FLUSHING 140 0.0014
822 SOMNOLENCE 277 0.0014
823 INJECTION SITE RASH 42 0.0014
824 THROMBOSIS 110 0.0014
825 ERECTILE DYSFUNCTION 35 0.0014
826 ECZEMA 71 0.0014
827 INJECTION SITE REACTION 93 0.0014
828 SKIN REACTION 19 0.0013
829 SPEECH DISORDER 70 0.0013
830 BRONCHOSPASM 19 0.0013
831 CHROMATURIA 30 0.0013
832 OCULAR HYPERAEMIA 63 0.0013
833 DEMENTIA 37 0.0013
834 RESPIRATORY TRACT CONGESTION 21 0.0013
835 LOCAL SWELLING 23 0.0013
836 ASTHMA 149 0.0013
837 URINARY INCONTINENCE 39 0.0013
838 BLOOD GLUCOSE INCREASED 248 0.0013
839 DEPRESSED LEVEL OF CONSCIOUSNESS 52 0.0013
840 ADVERSE EVENT 121 0.0013
841 UNEVALUABLE EVENT 99 0.0013
842 POST PROCEDURAL COMPLICATION 25 0.0013
843 HEMIPARESIS 22 0.0013
844 MUSCLE TIGHTNESS 21 0.0013
845 ADVERSE DRUG REACTION 116 0.0013
846 DISEASE PROGRESSION 152 0.0013
847 FEEDING DISORDER 26 0.0013
848 CHOKING 25 0.0013
849 VISUAL IMPAIRMENT 158 0.0013
850 RESPIRATORY ARREST 35 0.0013
851 INTENTIONAL PRODUCT MISUSE 111 0.0013
852 DISABILITY 25 0.0013
853 DEPRESSION 287 0.0013
854 LACRIMATION INCREASED 38 0.0013
855 FEELING COLD 35 0.0013
856 HYPOACUSIS 54 0.0013
857 ANXIETY 356 0.0012
858 VERTIGO 76 0.0012
859 INSURANCE ISSUE 19 0.0012
860 DRY EYE 62 0.0012
861 BALANCE DISORDER 107 0.0012
862 BACK DISORDER 20 0.0012
863 ANKLE FRACTURE 19 0.0012
864 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
865 CEREBROVASCULAR ACCIDENT 207 0.0012
866 FREQUENT BOWEL MOVEMENTS 33 0.0012
867 LABORATORY TEST ABNORMAL 36 0.0012
868 EYE DISORDER 40 0.0012
869 TREMOR 201 0.0012
870 VISION BLURRED 166 0.0012
871 PRURITUS GENERALISED 26 0.0012
872 SURGERY 70 0.0012
873 KNEE ARTHROPLASTY 25 0.0012
874 MUSCLE TWITCHING 27 0.0012
875 PSORIASIS 151 0.0012
876 EYE SWELLING 43 0.0012
877 THERAPY INTERRUPTED 82 0.0011
878 COLITIS ULCERATIVE 51 0.0011
879 ILL-DEFINED DISORDER 69 0.0011
880 HOSPITALISATION 174 0.0011
881 MIGRAINE 108 0.0011
882 NERVOUS SYSTEM DISORDER 35 0.0011
883 THIRST 20 0.0011
884 IRRITABLE BOWEL SYNDROME 24 0.0011
885 SKIN EXFOLIATION 94 0.0011
886 FUNGAL INFECTION 37 0.0011
887 DYSGEUSIA 82 0.0011
888 DRY SKIN 146 0.0011
889 SEROTONIN SYNDROME 21 0.0011
890 LOWER LIMB FRACTURE 21 0.0011
891 BLINDNESS 44 0.0011
892 NEUTROPHIL COUNT DECREASED 44 0.0011
893 FEAR 29 0.0011
894 ROAD TRAFFIC ACCIDENT 45 0.0011
895 HEAD DISCOMFORT 19 0.0011
896 NERVOUSNESS 56 0.0011
897 FEELING ABNORMAL 256 0.0011
898 PRODUCT DOSE OMISSION ISSUE 312 0.0011
899 PRODUCT AVAILABILITY ISSUE 24 0.0011
900 COMA 50 0.0010
901 PSYCHOTIC DISORDER 31 0.0010
902 TINNITUS 48 0.0010
903 EMOTIONAL DISORDER 32 0.0010
904 ERUCTATION 20 0.0010
905 EATING DISORDER 22 0.0010
906 MATERNAL EXPOSURE DURING PREGNANCY 92 0.0010
907 COGNITIVE DISORDER 48 0.0010
908 PRODUCT DOSE OMISSION 67 0.0010
909 OSTEONECROSIS 33 0.0010
910 CYTOKINE RELEASE SYNDROME 20 0.0010
911 AGITATION 73 0.0010
912 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
913 INJECTION SITE BRUISING 79 0.0010
914 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
915 AMNESIA 63 0.0010
916 CRYING 35 0.0010
917 APHASIA 29 0.0010
918 DYSKINESIA 39 0.0010
919 ABNORMAL BEHAVIOUR 38 0.0010
920 BLOOD GLUCOSE DECREASED 46 0.0010
921 RESTLESSNESS 35 0.0010
922 PROCEDURAL PAIN 26 0.0009
923 INJECTION SITE ERYTHEMA 115 0.0009
924 EXTRAPYRAMIDAL DISORDER 23 0.0009
925 INJECTION SITE PRURITUS 62 0.0009
926 DIPLOPIA 24 0.0009
927 SKIN IRRITATION 42 0.0009
928 EPILEPSY 28 0.0009
929 THERAPY CESSATION 47 0.0009
930 EMOTIONAL DISTRESS 108 0.0009
931 MEMORY IMPAIRMENT 121 0.0009
932 THERAPEUTIC RESPONSE SHORTENED 29 0.0009
933 MENTAL DISORDER 38 0.0009
934 DEATH 750 0.0009
935 MENTAL IMPAIRMENT 21 0.0009
936 CEREBRAL INFARCTION 21 0.0009
937 OSTEONECROSIS OF JAW 21 0.0008
938 PLASMA CELL MYELOMA 33 0.0008
939 INFLUENZA LIKE ILLNESS 69 0.0008
940 VISUAL ACUITY REDUCED 27 0.0008
941 FOETAL EXPOSURE DURING PREGNANCY 65 0.0008
942 INJECTION SITE SWELLING 61 0.0008
943 MOOD ALTERED 21 0.0008
944 SUICIDAL IDEATION 70 0.0008
945 DEPRESSED MOOD 40 0.0008
946 NEEDLE ISSUE 22 0.0008
947 EYE IRRITATION 42 0.0007
948 INCORRECT DOSE ADMINISTERED 166 0.0007
949 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
950 INJECTION SITE MASS 26 0.0007
951 INJECTION SITE PAIN 214 0.0007
952 DRUG ADMINISTRATION ERROR 21 0.0007
953 CONVULSION 39 0.0007
954 DRUG EFFECT DECREASED 36 0.0007
955 PANIC ATTACK 24 0.0007
956 FEMUR FRACTURE 20 0.0006
957 SEIZURE 74 0.0006
958 DISTURBANCE IN ATTENTION 33 0.0006
959 EYE PRURITUS 19 0.0006
960 IRRITABILITY 34 0.0006
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
962 ANGER 19 0.0006
963 PRODUCT SUBSTITUTION ISSUE 32 0.0006
964 AGGRESSION 27 0.0005
965 DEVICE DISLOCATION 23 0.0005
966 INJECTION SITE HAEMORRHAGE 42 0.0005
967 NEOPLASM MALIGNANT 35 0.0005
968 DERMATITIS ATOPIC 27 0.0005
969 DRUG DOSE OMISSION 84 0.0005
970 EXTRA DOSE ADMINISTERED 20 0.0005
971 UNDERDOSE 35 0.0005
972 LUNG NEOPLASM MALIGNANT 19 0.0005
973 VAGINAL HAEMORRHAGE 20 0.0005
974 MALIGNANT NEOPLASM PROGRESSION 47 0.0005
975 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 93 0.0005
976 ACNE 34 0.0004
977 DEVICE ISSUE 40 0.0004
978 DEVICE LEAKAGE 19 0.0004
979 SKIN BURNING SENSATION 30 0.0004
980 ACCIDENTAL EXPOSURE TO PRODUCT 42 0.0004
981 NO ADVERSE EVENT 73 0.0004
982 DRUG ABUSE 32 0.0004
983 DEVICE MALFUNCTION 27 0.0004
984 PROSTATE CANCER 29 0.0004
985 DRUG WITHDRAWAL SYNDROME 29 0.0003
986 PRODUCT QUALITY ISSUE 44 0.0003
987 DRUG DEPENDENCE 51 0.0003
988 PRODUCT STORAGE ERROR 26 0.0003
989 BREAST CANCER 23 0.0002